Busch Andreas 4
4 · Cyclerion Therapeutics, Inc. · Filed Nov 6, 2020
Insider Transaction Report
Form 4
Busch Andreas
Chief Innovation Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-11-04+75,000→ 75,000 totalExercise: $2.48Exp: 2030-11-04→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The Option vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of November 4, 2020.